In vitro removal of anti

The aim of this study is to describe the in vitro adsorption of anti-infective drugs onto an extracorporeal cytokine adsorber. Various anti-infective drugs (β-lactams, quinolones, aminoglycosides, glycopeptides, azole antimycotics) were prepared in normal saline 0.9% and human albumin 5%, and pumped through a cytokine cartridge (CytoSorb？; CytoSorbents Corporation, Monmouth Junction, NJ, USA) at a flow rate of 1.2？L/h for 1.5？h. In addition, meropenem and ciprofloxacin were dissolved in reconstituted blood and run through a CytoSorb cartridge, which was integrated into a continuous renal replacement therapy circuit with a flow rate of 2？L/h for 18？h. Samples from the solution, pre- and post-filter, were quantified by high-performance liquid chromatography with ultraviolet detection and fluorescence polarisation immunoassay. Observed mean clearance of the drugs in normal saline was 1.22？±？0.07？L/h. In human albumin, clearance was 1.29？±？0.08？L/h. In reconstituted blood, clearance of meropenem decreased from 5.4 to 1.4？L/h and for ciprofloxacin from 6.3 to 4.3？L/h within the first 1.5？h because of early drug adsorption. Continuous renal replacement therapy clearance measured without CytoSorb was stable at 2 and 1.7？L/h, respectively. Approximately 400？mg of meropenem and 300？mg of ciprofloxacin had been adsorbed by CytoSorb, suggesting that these amounts are the maximum adsorptive capacity for these drugs. In these settings, all tested drugs were adsorbed by the cartridge in relevant amounts. The identified maximum adsorptive capacity and the rapid decline in concentration during the first 1.5？h of CytoSorb use suggest that the administration of an additional dose within the first hours of CytoSorb treatment may be reasonable. In addition, early therapeutic drug monitoring should be considered